BioMarin Pharmaceutical (BMRN) Reports Q2 Loss of $0.04

August 7, 2007 4:55 PM EDT Send to a Friend
BioMarin Pharmaceutical (Nasdaq: BMRN) ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login